We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.35B
AUM Growth
-$265M
(-5.7%)
Cap. Flow
-$308M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
16.54%
Holding
629
New
5
Increased
18
Reduced
506
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.19M |
| 2 |
Medtronic
MDT
|
+$6.17M |
| 3 |
Qorvo
QRVO
|
+$3.05M |
| 4 |
Alkermes
ALKS
|
+$3M |
| 5 |
Comcast
CMCSA
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$15M |
| 2 |
Apple
AAPL
|
+$12.4M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$11M |
| 4 |
ExxonMobil
XOM
|
+$5.57M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 15.07% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Edwards Lifesciences
EW
$51B
| $3.38M | 0.08% |
142,344
-8,238
| -5% | -$185K |
|
302
Realty Income
O
$58.4B
| $3.37M | 0.08% |
67,236
-4,452
| -6% | -$223K |
|
|
ATVI
303
DELISTED
Activision Blizzard
ATVI
| $3.37M | 0.08% |
147,005
-10,107
| -6% | -$221K |
|
|
RHT
304
DELISTED
Red Hat Inc
RHT
| $3.36M | 0.08% |
44,413
| – | – |
|
|
SLXP
305
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $3.35M | 0.08% |
19,409
| – | – |
|
306
The Mosaic Company
MOS
$6.96B
| $3.35M | 0.08% |
72,615
-6,355
| -8% | -$310K |
|
307
Conagra Brands
CAG
$7.12B
| $3.34M | 0.08% |
117,367
-12,314
| -9% | -$339K |
|
308
Principal Financial Group
PFG
$24.5B
| $3.34M | 0.08% |
64,957
-5,466
| -8% | -$275K |
|
309
M&T Bank
MTB
$36.6B
| $3.34M | 0.08% |
26,267
-684
| -3% | -$82.8K |
|
310
FirstEnergy
FE
$27.8B
| $3.32M | 0.08% |
94,607
-5,521
| -6% | -$207K |
|
311
Keurig Dr Pepper
KDP
$42B
| $3.32M | 0.08% |
41,996
-3,949
| -9% | -$305K |
|
|
GGP
312
DELISTED
GGP Inc.
GGP
| $3.32M | 0.08% |
112,210
-4,800
| -4% | -$143K |
|
|
BBBY
313
DELISTED
Bed Bath & Beyond Inc
BBBY
| $3.31M | 0.08% |
43,139
-5,800
| -12% | -$440K |
|
314
Church & Dwight Co
CHD
$23.8B
| $3.31M | 0.08% |
77,492
-2,988
| -4% | -$124K |
|
315
NiSource
NI
$21B
| $3.3M | 0.08% |
190,442
-7,595
| -4% | -$129K |
|
|
HSP
316
DELISTED
HOSPIRA INC
HSP
| $3.29M | 0.08% |
37,472
-3,892
| -9% | -$305K |
|
317
W.W. Grainger
GWW
$60.8B
| $3.29M | 0.08% |
13,958
-875
| -6% | -$209K |
|
318
Nucor
NUE
$60.1B
| $3.29M | 0.08% |
68,611
-4,770
| -7% | -$223K |
|
319
CarMax
KMX
$8.37B
| $3.28M | 0.08% |
47,553
-3,929
| -8% | -$256K |
|
320
Signet Jewelers
SIG
$3.72B
| $3.28M | 0.08% |
23,632
| – | – |
|
321
Essex Property Trust
ESS
$18.2B
| $3.28M | 0.08% |
14,160
-1,060
| -7% | -$240K |
|
322
Alcoa
AA
$12.2B
| $3.25M | 0.07% |
104,656
-11,193
| -10% | -$402K |
|
323
Loews
L
$23.6B
| $3.24M | 0.07% |
79,437
-4,000
| -5% | -$162K |
|
324
Genuine Parts
GPC
$17.8B
| $3.21M | 0.07% |
34,427
-2,308
| -6% | -$222K |
|
325
Xerox
XRX
$419M
| $3.21M | 0.07% |
94,179
-6,759
| -7% | -$238K |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q1 2015 Portfolio in Review
As of Q1 2015, Fjarde Ap-fonden held 629 positions worth $4.35B, down 5.7% from $4.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fjarde Ap-fonden withdrew a net $308M in Q1 2015, closing 10 positions and reducing 506 holdings. Its most notable exit was Allergan Inc, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Fjarde Ap-fonden opened a new position in Qorvo worth $3.42M.
- Fjarde Ap-fonden's largest Q1 2015 buy was Qorvo: 42,872 shares worth $3.42M.
- Fjarde Ap-fonden added most to Allergan plc in Q1 2015, an estimated $6.19M increase.
- Fjarde Ap-fonden's biggest Q1 2015 reduction was Apple, cutting an estimated $12.4M.
- Fjarde Ap-fonden fully exited Allergan Inc in Q1 2015, selling an estimated $15M.
- Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.35B portfolio in Q1 2015.
- Fjarde Ap-fonden opened 5 new positions and closed 10 in Q1 2015.
- Fjarde Ap-fonden's portfolio value fell 5.7% quarter-over-quarter to $4.35B.
Based on Fjarde Ap-fonden's 13F filing for Q1 2015, filed 13 Apr 2015.